Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
revyve is a Dutch biotechnology company specializing in the production of sustainable, functional ingredients derived from upcycled brewer's yeast. The company utilizes a proprietary, non-GMO process to extract high-performance proteins and fibers that serve as clean-label alternatives to animal-based ingredients like eggs. Their products provide essential texturizing, binding, and emulsifying properties for the food industry, particularly in plant-based meat and bakery applications. By repurposing side streams from the brewing industry, revyve aims to reduce the environmental footprint of food production while meeting the demand for natural, allergen-free ingredients. The company is headquartered in Wageningen, the heart of the Netherlands' Food Valley, and operates a production facility to scale its circular economy solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on revyve.